Olarte Neal, Rivera Nina Thakkar, Grazette Luanda
Cardiovascular Division, University of Miami, Miami, FL, USA.
Cardiol Ther. 2022 Sep;11(3):369-384. doi: 10.1007/s40119-022-00274-6. Epub 2022 Aug 7.
Cardiogenic shock (CS) remains a leading cause of morbidity and mortality among patients with cardiovascular disease. In the past, acute myocardial infarction was the leading cause of CS. However, in recent years, other etiologies, such as decompensated chronic heart failure, arrhythmia, valvular disease, and post-cardiotomy, each with distinct hemodynamic profiles, have risen in prevalence. The number of treatment options, particularly with regard to device-mediated therapy has also increased. In this review, we sought to survey the medical literature and provide an update on current practices.
心源性休克（CS）仍然是心血管疾病患者发病和死亡的主要原因。过去，急性心肌梗死是CS的主要原因。然而，近年来，其他病因，如失代偿性慢性心力衰竭、心律失常、瓣膜病和心脏手术后，每种病因都有独特的血流动力学特征，其患病率有所上升。治疗选择的数量，特别是与设备介导的治疗有关的选择也有所增加。在本综述中，我们试图查阅医学文献并提供当前实践的最新情况。
